UCSF prof uses hyperpolarized MRI to target tumors, diseases

Melissa Rohman | | Health Imaging | Oncology Imaging

A group of researchers under the leadership of Daniel Vigneron, PhD, at the University of California, San Fransisco's Department of Radiology and Biomedical Imaging is in the process of developing hyperpolarized MRI techniques to detect, label and target brain and prostate tumors.   

“The goal of our research is to improve understanding of what causes diseases such as cancer, diabetes, liver and kidney disease, then come up with new ways to treat them, and then follow that with our techniques,” said Vigneron in a press release. 

Vigneron's work is allowing health imaging specialists to accurately identify, monitor and treat cancer and diseases.

See the full press release and learn more about Vigneron's work here:

Using Advanced MRI to Detect and Accurately Target Disease

""
Melissa Rohman

A recent graduate from Dominican University (IL) with a bachelor’s in journalism, Melissa joined TriMed’s Chicago team in 2017 covering all aspects of health imaging. She’s a fan of singing and playing guitar, elephants, a good cup of tea, and her golden retriever Cooper.

Related Content

MRI-first approach could allow many to safely forego prostate biopsy
MRI guidance significantly reduces radiotherapy side effects compared to CT
Interventional procedure often as effective as surgery for difficult-to-treat liver cancer
AI tumor volume estimations could improve prostate cancer treatment strategies
MRI could be 'powerful tool' for guiding surgery decisions in patients with rectal cancer
Breast cancer only visible via MRI is often less aggressive

Around the web

Cardiovascular Business
Cardiology, radiology specialists debate CCTA’s rise as a go-to imaging modality for CAD

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

Cardiovascular Business
New AI program delivers rapid, accurate echo video assessments

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Radiology Business
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.